Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1)

被引：114

作者：

Niemi, M

Kivistö, KT

Hofmann, U

Schwab, M

Eichelbaum, M

Fromm, MF

机构：

[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany

[2] Univ Erlangen Nuremberg, Inst Expt & Clin Pharmacol & Toxicol, Erlangen, Germany

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2005年 / 59卷 / 05期

关键词：

D O I：

10.1111/j.1365-2125.2005.02354.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：602 / 604

页数：3

共 16 条

[1]

Cvetkovic M, 1999, DRUG METAB DISPOS, V27, P866

[2] MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine [J].

Drescher, S ;

Schaeffeler, E ;

Hitzl, M ;

Hofmann, U ;

Schwab, M ;

Brinkmann, U ;

Eichelbaum, M ;

Fromm, MF .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (05) :526-534

[3] Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine [J].

Dresser, GK ;

Bailey, DG ;

Leake, BF ;

Schwarz, UI ;

Dawson, PA ;

Freeman, DJ ;

Kim, RB .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (01) :11-20

[4] Clinical pharmacokinetics of pravastatin - Mechanisms of pharmacokinetic events [J].

Hatanaka, T .

CLINICAL PHARMACOKINETICS, 2000, 39 (06) :397-412

[5] A novel human hepatic organic anion transporting polypeptide (OATP2) - Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters [J].

Hsiang, BN ;

Zhu, YJ ;

Wang, ZQ ;

Wu, YL ;

Sasseville, V ;

Yang, WP ;

Kirchgessner, TG .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (52) :37161-37168

[6] Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene [J].

Johne, A ;

Köpke, K ;

Gerloff, T ;

Mai, I ;

Rietbrock, S ;

Meisel, C ;

Hoffmeyer, S ;

Kerb, R ;

Fromm, MF ;

Brinkmann, U ;

Eichelbaum, M ;

Brockmöller, J ;

Cascorbi, I ;

Roots, I .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (05) :584-594

[7] Identification of functionally variant MDR1 alleles among European Americans and African Americans [J].

Kim, RB ;

Leake, BF ;

Choo, EF ;

Dresser, GK ;

Kubba, SV ;

Schwarz, UI ;

Taylor, A ;

Xie, HG ;

McKinsey, J ;

Zhou, S ;

Lan, LB ;

Schuetz, JD ;

Schuetz, EG ;

Wilkinson, GR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (02) :189-199

[8] Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane [J].

Kobayashi, D ;

Nozawa, T ;

Imai, K ;

Nezu, JI ;

Tsuji, A ;

Tamai, I .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 306 (02) :703-708

[9] Identification of nonsynonomous polymorphisms of human organic anion transporting polypeptide-A (OATP-A) associated with altered transport activity. [J].

Lee, W ;

Smith, LH ;

Gervasini, G ;

Leake, BF ;

Kim, RB .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) :P93-P93

[10] Pharmacogenomics of the OATP and OAT families [J].

Marzolini, C ;

Tirona, RG ;

Kim, RB .

PHARMACOGENOMICS, 2004, 5 (03) :273-282

← 1 2 →